Back to News
Market Impact: 0.18
Roche, Genentech Expand U.S. Research Footprint With New Boston Center
Source: Nasdaq
Healthcare & BiotechTechnology & Innovation
Roche opened the Roche Genentech Innovation Center Boston, expanding its and wholly owned subsidiary Genentech's U.S. research footprint. The move strengthens Roche's presence in Boston's major life-sciences ecosystem, but the announcement provided no financial investment, pipeline, or earnings impact details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- UBS downgrades Roche stock rating to neutral on valuation concerns
- Nurix Therapeutics CSO Gwenn Hansen sells $142,899 in stock
- Marvell to buy Lumentum in $115 billion deal in AI data-center bet
- Marvell, Lumentum tout historic $115B deal to create ‘category leader' in AI connectivity
- The AI boom is facing another supply crunch. This time it’s the amount of capital available to feed Silicon Valley’s endless need for cash
- New Apple CEO John Ternus chalks up some early wins, but the honeymoon is over